<?xml version="1.0" encoding="UTF-8"?>
<p>During the dengue fever epidemics in 2016, a new indirect immunofluorescence (IIF) test, the BIOCHIP
 <sup>Â®</sup> mosaic developed in Germany and promising to serologically detect the dengue, Zika and Chikungunya viruses, was released in Brazil to compete with ELISA assays, which had been used as routine for a longer time.
</p>
